“Prescription stimulants reduce ADHD symptoms in adults with ADHD.”
Prescription stimulant medicines reduce core ADHD symptoms for many adults with a confirmed diagnosis, especially over the short term studied in trials.
Stimulants are a proven option for adults with ADHD, but working well on average does not mean every medicine or dose is right for every person.
If ADHD is impairing daily life, discuss medication and non-medication options with a qualified clinician and agree on how benefit and side effects will be monitored.
Safety note: Stimulants can raise heart rate and blood pressure and have misuse or diversion potential. They require an individualized prescription and monitoring.
Talk to a healthcare professional if: you have heart problems or high blood pressure, take other medicines, have a history of substance use, or notice sleep problems or other side effects. Never use another person's prescription.
Strong confidence because two large network meta-analyses of randomized trials found that stimulants reduce core ADHD symptoms in adults over the short term, with benefit reported by clinicians and patients. Long-term benefit and tolerability are separate questions.
Medication response varies. Treatment also considers impairment, goals, side effects, other conditions and non-medication support.
- Ostinelli EG, Schulze M, Zangani C, Farhat LC, Tomlinson A, Del Giovane C, et al. Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. Lancet Psychiatry. 2025;12(1):32-43. DOI: 10.1016/S2215-0366(24)00360-2. PMID: 39701638
- Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. DOI: 10.1016/S2215-0366(18)30269-4. PMID: 30097390. PMCID: PMC6109107
- National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (NG87). Published March 14, 2018; last updated September 13, 2019
- U.S. Food and Drug Administration. FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions. Drug Safety Communication, May 11, 2023; content current as of April 3, 2026